OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	122
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	88
TREM-2: friend or foe in infectious diseases?	68
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	63
Salmonella in eggs and egg-laying chickens: pathways to effective control	59
Current and emerging therapies for fungal biofilms and systemic infections	50
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	49
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	43
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	43
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	42
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	40
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	40
Elucidating the multifaceted antibacterial mechanisms of luteolin: insights, challenges, and prospects for clinical translation	36
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
Exploring halophilic environments as a source of new antibiotics	32
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses	30
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	29
LysR-type transcriptional regulators: state of the art	29
Vibrio cholerae virulence and its suppression through the quorum-sensing system	28
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma	27
Helicobacter pylori ’s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread	26
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties	25
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	25
Polyamine as a microenvironment factor in resistance to antibiotics	23
Bacterial vaginosis: advancing insights into microbial dysbiosis	22

The diffusible signaling factor family in microbial signaling: a current perspective	22
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	22
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	21
Recent advances in omics-driven research of photosynthetic microorganisms in green biotechnology	21
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	21
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	20
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	19
Microbial persisters and host: recent advances and future perspectives	19
Molecular mechanisms of Klebsiella pneumoniae pathogenicity: from virulence factors to emerging therapeutic strategies	19
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	18
Biotherapeutic potential of gut microbiota-derived indole-3-acetic acid	18
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	17
The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment	17
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	17
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	17
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	16
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	16
Bacterial kinase in ESKAPE pathogen: regulators of virulence and novel therapeutic targets	16
Revisiting the antimicrobial potential of metalloporphyrins: from food to pharma	16
Aspergilli series Versicolores: importance of species identification in the clinical setting	15
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	15
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	15
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects	15
The crosstalk between SUMOylation and immune system in host-pathogen interactions	15
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	15
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	14
Anti-virulence peptides: a compromising strategy to treat Staphylococcus aureus chronic wound infection	14
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	14